abstract |
The present invention relates to a phosphodiesterase type III (PDE III) inhibitor or a "Ca 2 + sensitizer" or pharmaceutically acceptable for the manufacture of a medicament for reducing the heart size of a patient suffering from heart failure. It relates to the use of derivatives thereof.n n n n Heart, heart failure, heart size, phosphodiesterase, PDE, calcium, Ca2 + sensitizer |